Cargando…
The evolution of clinical trials for infant acute lymphoblastic leukemia
Acute lymphoblastic leukemia (ALL) in infants has a significantly inferior outcome in comparison with older children. Despite initial improvements in survival of infants with ALL since establishment of the first pediatric cooperative group ALL trials, the poor outcome has plateaued in recent years....
Autores principales: | Kotecha, R S, Gottardo, N G, Kees, U R, Cole, C H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4003413/ https://www.ncbi.nlm.nih.gov/pubmed/24727996 http://dx.doi.org/10.1038/bcj.2014.17 |
Ejemplares similares
-
Systematic chemical and molecular profiling of MLL-rearranged infant acute lymphoblastic leukemia reveals efficacy of romidepsin
por: Cruickshank, M N, et al.
Publicado: (2017) -
Preclinical Evaluation of Carfilzomib for Infant KMT2A-Rearranged Acute Lymphoblastic Leukemia
por: Cheung, Laurence C., et al.
Publicado: (2021) -
A pre-clinical model of resistance to induction therapy in pediatric acute lymphoblastic leukemia
por: Samuels, A L, et al.
Publicado: (2014) -
Increased Body Mass Index during Therapy for Childhood Acute Lymphoblastic Leukemia: A Significant and Underestimated Complication
por: Atkinson, Helen C., et al.
Publicado: (2015) -
Epigenetic Control of Infant B Cell Precursor Acute Lymphoblastic Leukemia
por: de Barrios, Oriol, et al.
Publicado: (2021)